Maintenance darunavir/ritonavir monotherapy to prevent perinatal HIV transmission, ANRS-MIE 168 MONOGEST study.

Laurent MandelbrotRoland TubianaPierre Frange Gilles PeytavinJerome Le ChenadecAna CanestriPhilippe MorlatCécile Brunet-CartierJeanne SibiudeDelphine PerettiVéronique ChambrinAmélie ChabrolEida BuiCaroline Simon-ToulzaLucie MarchandChristelle PaulSandrine DelmasVeronique Avettand-FenoelJosiane Warszawskinull null

Published in: The Journal of antimicrobial chemotherapy (2023)

Darunavir/ritonavir maintenance monotherapy required intensification in nearly 10% of cases. This limits its widespread use, thus other regimens should be evaluated in order to limit exposure to antiretrovirals, particularly NRTIs, during pregnancy.

Keyphrases

antiretroviral therapy
hiv infected patients
hiv infected
human immunodeficiency virus
combination therapy
hiv positive
open label
hiv aids
hepatitis c virus
pregnant women
hiv testing
clinical trial